Clinical Use of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) in the Management of Hemorrhage Control: Where Are We Now?

Amanda M. Marsh, Richard Betzold, Mario Rueda, Megan Morrow, Lawrence Lottenberg, Robert Borrego, Mira Ghneim, Joseph J. DuBose, Jonathan J. Morrison, Faris K. Azar*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Purpose of Review: Hemorrhagic shock remains the leading cause of potentially preventable death following traumatic injuries. Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) has demonstrated promising results in the control of non-compressible torso hemorrhage. The purpose of this review is to summarize the indications, procedural techniques, and complications of REBOA in order to help define practice management guidelines. Recent Findings: Recent studies suggest that REBOA is advantageous in aiding hemodynamic stabilization as a bridge to definitive hemorrhage control. REBOA is a feasible option for non-compressible torso hemorrhage as well as traumatic cardiac arrest and has the potential to improve morbidity and mortality in select patient populations. Summary: Despite favorable emerging data, varying results in the literature indicate the need for further high-quality reproducible data and multicenter trials to identify the ideal clinical scenarios for REBOA. This review discusses special considerations and future directions for next generation REBOA use.

Original languageEnglish
Article number5
JournalCurrent Surgery Reports
Volume9
Issue number3
DOIs
StatePublished - Mar 2021
Externally publishedYes

Keywords

  • Aortic balloon occlusion
  • Endovascular therapy
  • Hemorrhagic shock
  • REBOA
  • Trauma
  • Trauma resuscitation

Fingerprint

Dive into the research topics of 'Clinical Use of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) in the Management of Hemorrhage Control: Where Are We Now?'. Together they form a unique fingerprint.

Cite this